Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

Sylvia Ammoun, D Gareth Evans, David Hilton, Adam Streeter, Christopher Hayward, C Oliver Hanemann

Research output: Contribution to journal › Article › peer-review

73 Downloads (Pure)

Original language	English
Journal	Journal of Neurology, Neurosurgery and Psychiatry
Early online date	4 Feb 2019
DOIs	https://doi.org/10.1136/jnnp-2018-319713
Publication status	Published - Feb 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{8c6749f255b04ed588a25a25a6dc525b,

title = "Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2",

author = "Sylvia Ammoun and Evans, {D Gareth} and David Hilton and Adam Streeter and Christopher Hayward and Hanemann, {C Oliver}",

year = "2019",

month = feb,

doi = "10.1136/jnnp-2018-319713",

language = "English",

journal = "Journal of Neurology, Neurosurgery and Psychiatry ",

issn = "0022-3050",

publisher = "BMJ ",

}

TY - JOUR

T1 - Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

AU - Ammoun, Sylvia

AU - Evans, D Gareth

AU - Hilton, David

AU - Streeter, Adam

AU - Hayward, Christopher

AU - Hanemann, C Oliver

PY - 2019/2

Y1 - 2019/2

UR - http://europepmc.org/abstract/med/30718294

U2 - 10.1136/jnnp-2018-319713

DO - 10.1136/jnnp-2018-319713

M3 - Article

C2 - 30718294

SN - 0022-3050

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

ER -